Thomas d’Amato - Concepedia

Concepedia

Author

Thomas d’Amato

University of Pittsburgh Medical Center

Also Known As

Thomas A d’Amato, Thomas A. D’Amato, Thomas A. d'Amato, Thomas A. dAmato, Thomas A. d‘Amato, Thomas A. d’Amato, Thomas d’Amato

22

Publications

1.2K

Citations

14

H-Index

36

Concepts

All Affiliations

University of Pittsburgh Medical Center Allegheny General Hospital University of Pittsburgh Jefferson College UPMC Presbyterian

TD

About

Thomas d’Amato is an author at University of Pittsburgh Medical Center specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	967
2	Health Sciences	2	2	82
3	Public Health	1	1	23
4	Cell Biology	1	1	208
5	Emergency Medicine	1	1	23

Thomas d’Amato

×

15

Publications

1.2K

Citations

14

H-Index

	Year	Citations
Anatomic Segmentectomy in the Treatment of Stage I Non-Small Cell Lung Cancer Matthew J. Schuchert, Brian Pettiford, Samuel B. Keeley, The Annals of Thoracic Surgery Surgical OncologyMedicineMultiple Pulmonary NoduleThoracic SurgerySurgery	2007	331
Vascular Endothelial Growth Factor Expression in Stage I Non-Small Cell Lung Cancer Correlates With Neoangiogenesis and a Poor Prognosis Helen Han, Jan F. Silverman, Tibetha Santucci, Annals of Surgical Oncology AngiogenesisMedicinePathologyBronchial NeoplasmVascular Biology	2001	208
Minimally invasive resection of benign esophageal tumors Michael S. Kent, Thomas d’Amato, C. H. Nordman, Journal of Thoracic and Cardiovascular Surgery Surgical OncologyEsophagusEsophageal CancerSurgeryInvasive Resection	2007	113
Intraoperative Brachytherapy Following Thoracoscopic Wedge Resection of Stage I Lung Cancer Thomas d’Amato, Michael Galloway, Gary W Szydlowski, CHEST Journal Surgical OncologyMedicineBrachytherapyBronchial NeoplasmThoracic Surgery	1998	93
Chemotherapy resistance and oncogene expression in non–small cell lung cancer Thomas d’Amato, Rodney J. Landreneau, William Ricketts, Journal of Thoracic and Cardiovascular Surgery	2007	76
Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma Alex Chen, Michael Galloway, Rodney Landreneau, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyHigh-risk StageRadiation TherapyMedicineCell Lung Carcinoma	1999	67
Combined Angiotensin II Receptor Antagonism and Angiotensin-Converting Enzyme Inhibition Further Attenuates Postinfarction Left Ventricular Remodeling Sunil Mankad, Thomas d’Amato, Nathaniel Reichek, Circulation	2001	52
Prevalence of In Vitro Extreme Chemotherapy Resistance in Resected Nonsmall-Cell Lung Cancer Thomas d’Amato, Rodney J. Landreneau, Robert J. McKenna, The Annals of Thoracic Surgery Surgical OncologyMedicinePathologyBronchial NeoplasmMetronomic Chemotherapy	2006	50
A unique atrial primary cardiac lymphoma mimicking myxoma presenting with embolic stroke: a case report Michael Quigley, Eric Schwartzman, Pamela D. Boswell, Blood	2003	46
Risk of Pneumonectomy After Induction Therapy for Locally Advanced Non-Small Cell Lung Cancer Thomas d’Amato, Ahmad S. Ashrafi, Matthew J. Schuchert, The Annals of Thoracic Surgery Surgical OncologyOncologyBronchial NeoplasmThoracic SurgerySurgery	2009	43

Page 1